References
- Astrup T. Über die Standardisierung des Heparins. Enzymologia 1938; 5: 12
- Astrup T. The toxicity of synthetic heparin substitutes. Scandinav. J. Clin. & Lab. Investigation 1953; 5: 137
- Astrup T., Galsmar I. On the anticoagulant activity of heparin and synthetic polysaccharide sulphuric acids. Acta Physiol. Scandinav. 1944; 8: 361
- Astrup T., Galsmar I., Volkert M. Polysaccharide sulphuric acids as anticoagulants. Acta Physiol. Scandinav. 1944; 8: 215
- Astrup T., Jensen H. B. Purification of heparin. Scandinav. Arch. Physiol. 1938; 79: 290
- Blombäck B., Blombäck M., Corneliusson E. V., Jorpes J. E. On the reliability of the methods used in the assay of heparin. J. Pharm. Pharmacol. 1953; 5: 1031
- Fischer A., Astrup T. Measurement of the inhibitory action of anticoagulants. Proc. Soc. Exp. Biol. Med. 1938; 38: 494
- Fischer A., Schmitz A. Über die chemische Natur des Heparins. I. Die quantitative Bestimmung des Heparins. Zeitschr. physiol. Chem. 1932; 210: 129
- Grönwall A., Ingelman B., Mosimann H. A dextran sulphuric acid ester with heparin activity. Uppsala Läkarefören. Förhandl. N. F. 1945; 50: 397
- Husemann E., Pfannemüller B., Hertlein W., Hoffmann E. G. Über die Ausscheidung und Speicherung von radioaktiv indizierten Xylan-Schwefelsäreestern. IV. Mitt. Zeitschr. f. Naturforschung 1954; 9 b: 704
- Kuizenga M. H., Nelson J. W., Cartland G. F. The bioassay of heparin preparations. Am. J. Physiol. 1943; 139: 612
- Piper J. Influence of synthetic polysaccharid sulphuric acid esters on the thrombocytes in vivo and in vitro. Acta Physiol. Scandinav. 1945; 9: 28
- Piper J. The anticoagulant effect of heparin and synthetic polysaccharide polysulphuric acid esters. Acta Pharmacol. et Toxicol. 1946a; 2: 138
- Piper J. Toxicology of synthetic polysaccharide polysulphuric acid esters. Acta Pharmacol. et Toxicol. 1946b; 2: 317
- Ricketts C. R. Dextran sulphate. A synthetic analogue of heparin. Biochem. J. 1952; 51: 129
- Ricketts C. R., Walton K. W., van Leuven B. D., Birbeck A., Brown A., Kennedy A. C., Burt C. C. Therapeutic trial of the synthetic heparin analogue dextran sulphate. Lancet 1953; 2: 1004
- Walton K. W. Experiments with dextran sulphate as an anticoagulant. Proc. Roy. Soc. Med. 1951; 44: 563
- Walton K. W. The biological behaviour of a new synthetic anticoagulant (dextran sulphate) possessing heparin-like properties. Brit. J. Pharmacol. 1952; 7: 370
- Walton K. W. Observations on the effect of a series of dextran sulphates of varying molecular weight on the formed elements of the blood in vitro. Brit. J. Pharmacol. 1953; 8: 340
- Walton K. W. Investigations of the toxicity of a series of dextran sulphates of varying molecular weight. Brit. J. Pharmacol. 1954; 9: 1
- Yamashina I. Note on β-Heparin. Acta Chem. Scandinav. 1954; 8: 1316